Applied Clinical Trials
In clinical trials, the need for globally accessible toll-free and other phone numbers for trial functions is vital.
In clinical trials, the need for globally accessible toll-free and other phone numbers for trial functions is vital. But because of the way international telephone carrier services are set up, phone numbers may be left inoperable.
According to Stephen Levenson, Vice President of Global Telecom Testing, international telecommunications companies rent phone lines from local carriers. These companies have no control over the line or service and are dependent on the local carrier. This may not sound problematic, until a number doesn't work. Then it could mean days of downtime to resolve issues.
Levenson's company offers multi-faceted in-country, live human testing of phone numbers. These tests are done within the country to attempt completing outbound calls to ensure the number(s) works. This is different than testing a number by computer, because computers can't determine if customers will be able to call the designated number from in-country local access points, if they can hear clearly, or if other call quality issues are present. Global Telecom Testing offers an additional service through its relationship with locally-based phone carriers to resolve phone issues directly.
Other issues with international calling and their local exchange carrier partners assume that an international telephone number is operational just because it has worked in the past. In addition, some countries or regions have no industry standard or phone company regulation.
Global Telecom Testing's technicians have discovered improper carrier provisioning, improper passcode designation, improper message authentication, echo, static, post dial delay, network inaccessibility, carrier activation failures, and on-site blocking of 800 numbers.
Levenson told Applied Clinical Trials, "What we have found over the past three years is up to 40% of these numbers are not operational when they are handed off to go live. This is a colossal fail for a clinical trial."
—Lisa Henderson
AI in Clinical Trials: A Long, But Promising Road Ahead
May 29th 2024Stephen Pyke, chief clinical data and digital officer, Parexel, discusses how AI can be used in clinical trials to streamline operational processes, the importance of collaboration and data sharing in advancing the use of technology, and more.
Ponsegromab Significantly Improves Body Weight in Patients with Cancer Cachexia
September 17th 2024Results of a Phase II study of ponsegromab showed significant improvements in body weight, muscle function, and overall symptoms for patients with cancer cachexia, offering hope for a new targeted treatment.
Including Women of Childbearing Age in Clinical Research
March 26th 2024In recognition of International Women's Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and Marie Teil, Global Head of UCB’s Women of Childbearing Age Program. They speak about the specific challenges women with chronic illnesses face when accessing appropriate treatment and participating in clinical trials, UCB's Women of Childbearing Age Program and it’s most successful strategies, and much more.